8-(4-Hydroxy-bicyclo[2.2.2]oct-1-yl)-6-(1-hydroxymethyl-propylamino)-3-propyl-3,7-dihydro-purin-2-one → 8-ethyl-2-(4-hydroxy-1-bicyclo[2.2.2]octanyl)-4-propyl-7,8-dihydro-1H-imidazo[2,1-f]purin-5-one

HRID 1793813Notes

Reaction equation

HRID 1793813 reaction equation
[OH:1][C:2]12[CH2:9][CH2:8][C:5]([C:10]3[NH:18][C:17]4[C:16]([NH:19][CH:20]([CH2:23]O)[CH2:21][CH3:22])=[N:15][C:14](=[O:25])[N:13]([CH2:26][CH2:27][CH3:28])[C:12]=4[N:11]=3)([CH2:6][CH2:7]1)[CH2:4][CH2:3]2>O=S(Cl)Cl>[CH2:21]([CH:20]1[N:19]=[C:16]2[N:15]([C:14](=[O:25])[N:13]([CH2:26][CH2:27][CH3:28])[C:12]3[N:11]=[C:10]([C:5]45[CH2:4][CH2:3][C:2]([OH:1])([CH2:9][CH2:8]4)[CH2:7][CH2:6]5)[NH:18][C:17]=32)[CH2:23]1)[CH3:22]

Participants

3

Reactant 1

HCID 691480518-(4-Hydroxy-bicyclo[2.2.2]oct-1-yl)-6-(1-hydroxymethyl-propylamino)-3-propyl-3,7-dihydro-purin-2-one

Product 1

HCID 1784565778-ethyl-2-(4-hydroxy-1-bicyclo[2.2.2]octanyl)-4-propyl-7,8-dihydro-1H-imidazo[2,1-f]purin-5-oneYield 47.7%

Reagents, catalysts & solvents 1

HCID 24386Thionyl ChlorideSolvent

Procedure

8-(4-Hydroxy-bicyclo[2.2.2]oct-1-yl)-6-(1-hydroxymethyl-propylamino)-3-propyl-3,7-dihydro-purin-2-one (110 mg) was dissolved in 3 mL of SOCl2 and stirred under reflux for 20 min. It was then cooled to rt and concentrated. The residue was quenched with saturated aq NaHCO3 and extracted with CHCl3. The combined organic layers were dried (Na2SO4) and concentrated under reduced pressure. Purification by preparative HPLC afforded 50 mg of the titled compound as the TFA salt.

Workup

  1. temperatureunder reflux for 20 min
  2. concentrationconcentrated
  3. customThe residue was quenched with saturated aq NaHCO3
  4. extractionextracted with CHCl3
  5. dry with materialThe combined organic layers were dried (Na2SO4)
  6. concentrationconcentrated under reduced pressure
  7. customPurification by preparative HPLC

Sources & evidence

ORD record
ord-aa9d63b069844e7797119f3df4bc88f0
Source dataset
uspto-grants-2006_04
Patent number
US07022686B2

Reaction notes

Loading…